Instil Bio, Inc.
TIL
$12.70
-$1.35-9.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 52.50% | 61.85% | 35.64% | 45.46% | 30.06% |
| Total Depreciation and Amortization | -24.10% | -32.89% | -41.85% | -42.12% | -20.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -64.97% | -77.48% | 8.38% | -3.48% | 68.09% |
| Change in Net Operating Assets | -39.81% | 29.41% | 109.63% | 8.12% | 5.75% |
| Cash from Operations | 32.10% | 44.60% | 60.01% | 61.35% | 54.47% |
| Capital Expenditure | -- | 99.83% | 90.28% | 83.25% | 75.57% |
| Sale of Property, Plant, and Equipment | -44.38% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.83% | -43.50% | -70.34% | -62.52% | -69.75% |
| Cash from Investing | 31.23% | -8.43% | -54.92% | -30.00% | -64.09% |
| Total Debt Issued | 887.43% | -100.00% | -100.00% | -94.38% | -87.68% |
| Total Debt Repaid | -14,012.10% | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -57.71% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -78.29% | -98.89% | -101.98% | -95.24% | -88.76% |
| Foreign Exchange rate Adjustments | 53.23% | 57.14% | 70.34% | 82.73% | 68.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.82% | 88.93% | 19.43% | 33.60% | -686.92% |